Peter Attia· MD
the drugs that we are interested in by by designing our program are drugs that are designed to win at our program you've got to be at least three times better than a complete conquest of cancer
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the drugs that we are interested in by by designing our program are drugs that are designed to win at our program you've got to be at least three times better than a complete conquest of cancer
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.